{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:53:05Z","timestamp":1777575185158,"version":"3.51.4"},"reference-count":51,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education and National Research Foundation of Korea","award":["1345370673"],"award-info":[{"award-number":["1345370673"]}]},{"name":"Ministry of Education and National Research Foundation of Korea","award":["LINC3.0-2023-54"],"award-info":[{"award-number":["LINC3.0-2023-54"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Age-related macular degeneration (AMD) is an age-associated retinal disorder characterized by blood\u2013retinal barrier (BRB) breakdown and pathological angiogenesis, leading to vascular leakage. The intravitreal administration of anti-VEGF agents remains the most effective treatment for neovascular AMD. However, repetitive intravitreal injections have risks, causing side effects such as cataracts, bleeding, retina damage, and, in severe cases, post-injection endophthalmitis. Hence, the development of innovative drug delivery systems is essential to minimize the risks and discomfort associated with intravitreal injections. Materials and Methods: We developed a microemulsion (ME)-based topical drug delivery system incorporating \u03b1-linolenic acid (ALA). In brief, pseudo-ternary phase diagrams were constructed by the water titration method using different combinations of surfactants and cosurfactants (Smix-Cremophor RH 40: Span 80: Transcutol P in ratios of 1:1.05, 1:1:1, 1:1:1.5) containing ALA as the oil phase. Three blank microemulsions (ME1, ME2, and ME3) were prepared and characterized based on the optimized pseudo-ternary phase equilibrium with a Smix ratio of 1:1:1. Results: ME3, with an average particle size of 38.59 nm, was selected as the optimized formulation for developing drug-loaded ME containing Fenofibrate, Axitinib, and Sirolimus. The drug-loaded ME showed particle size (46.94\u201356.39 nm) and in vitro release displayed sustained and longer time drug release for 240 h. The irritation and antiangiogenic activities were evaluated using the hen\u2019s egg chorioallantoic membrane (HET-CAM) assay employing the optimized ME loaded with each drug. Among the three drug-loaded ME, the Sirolimus ME showed a reduction in blood vessel sprouting in the HET-CAM assay, indicating strong antiangiogenic activity. Treatment with the optimized blank ME and Sirolimus ME significantly (p &lt; 0.05) reduced COX-2 protein expression in LPS-stimulated RAW 264.7 cells, suggesting their potential anti-inflammatory effects. Conclusions: Overall, we suggest that the \u03b1-linolenic acid-based Sirolimus microemulsion may serve as a promising topical therapeutic approach for managing AMD and offering a potential alternative to invasive intravitreal injections.<\/jats:p>","DOI":"10.3390\/medicina61112030","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:06:36Z","timestamp":1763111196000},"page":"2030","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Formulation of \u03b1-Linolenic Acid-Based Microemulsions for Age-Related Macular Degeneration: Physicochemical Tests and HET-CAM Assays for Anti-Angiogenic Activities"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-5494","authenticated-orcid":false,"given":"Sang Gu","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Biotechnology, College of Life and Applied Sciences, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, College of Life and Applied Sciences, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gibaek","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, College of Life and Applied Sciences, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Eun","family":"Lee","sequence":"additional","affiliation":[{"name":"Stemforce, 313 Institute of Industrial Technology, Yeungnam University, Gyeongsan 38541, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-2358","authenticated-orcid":false,"given":"Ramachandran","family":"Vinayagam","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, College of Life and Applied Sciences, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., and Qiu, Q. (2022). Diabetic macular edema: Current understanding, molecular mechanisms and therapeutic implications. Cells, 11.","DOI":"10.3390\/cells11213362"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/opo.12675","article-title":"Risk factors for progression of age-related macular degeneration","volume":"40","author":"Heesterbeek","year":"2020","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12987-018-0109-2","article-title":"The role of plasmalemma vesicle-associated protein in pathological breakdown of blood\u2013brain and blood\u2013retinal barriers: Potential novel therapeutic target for cerebral edema and diabetic macular edema","volume":"15","author":"Bosma","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40942-024-00603-y","article-title":"Diabetic macular edema (DME): Dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights","volume":"10","author":"Hamid","year":"2024","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Shyam, M., Sidharth, S., Veronica, A., Jagannathan, L., Srirangan, P., Radhakrishnan, V., and Sabina, E.P. (2025). Diabetic retinopathy: A comprehensive review of pathophysiology and emerging treatments. Mol. Biol. Rep., 52.","DOI":"10.1007\/s11033-025-10490-7"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1189\/jlb.3RU0417-139","article-title":"Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?","volume":"102","author":"Hughes","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Haydinger, C.D., Ferreira, L.B., Williams, K.A., and Smith, J.R. (2023). Mechanisms of macular edema. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1128811"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.coph.2024.102463","article-title":"Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration","volume":"76","author":"Vessey","year":"2024","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/aos.15224","article-title":"Visual impairment due to age-related macular degeneration during 40 years in Finland and the impact of novel therapies","volume":"101","author":"Purola","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Singh, M., Negi, R., Alka Vinayagam, R., Kang, S.G., and Shukla, P. (2024). Age-related macular degeneration (AMD): Pathophysiology, drug targeting approaches, and recent developments in nanotherapeutics. Medicina, 60.","DOI":"10.3390\/medicina60101647"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Liao, Z.-Y., Hung, C.-Y., Hsu, Y.-J., Liang, I.-C., Chen, Y.-C., Sung, C.-H., and Hung, C.-F. (2025). Phlorizin Protects Against Oxidative Stress and Inflammation in Age-Related Macular Degeneration Model. Biomolecules, 15.","DOI":"10.3390\/biom15040523"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41433-025-03774-6","article-title":"The global burden and attributable risk factor analysis of age-related macular degeneration in 204 countries and territories, 1990\u20132021","volume":"39","author":"Wang","year":"2025","journal-title":"Eye"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.oret.2024.02.012","article-title":"Evaluating the efficacy and safety of aflibercept biosimilar (P041) compared with originator product in patients with neovascular age-related macular degeneration","volume":"8","author":"Karkhaneh","year":"2024","journal-title":"Ophthalmol. Retin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"118767","DOI":"10.1016\/j.ijpharm.2019.118767","article-title":"Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration","volume":"573","author":"Aguiar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Callan, A., Heckman, J., Tah, G., Lopez, S., Valdez, L., and Tsin, A. (2025). VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26114992"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.drudis.2022.04.013","article-title":"Novel and investigational therapies for wet and dry age-related macular degeneration","volume":"27","author":"Sarkar","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1007\/s10792-023-02853-5","article-title":"Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): A scoping review","volume":"43","author":"Ghule","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature","volume":"27","author":"Nguyen","year":"2013","journal-title":"Eye"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/OPX.0000000000001826","article-title":"Effect of a novel omega-3 and omega-6 fatty acid supplement on dry eye disease: A 3-month randomized controlled trial","volume":"99","author":"Ng","year":"2022","journal-title":"Optom. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/nure.12145","article-title":"Efficacy of polyunsaturated fatty acids for dry eye syndrome: A meta-analysis of randomized controlled trials","volume":"72","author":"Zhu","year":"2014","journal-title":"Nutr. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/ICO.0000000000001884","article-title":"Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: A meta-analysis of randomized clinical trials","volume":"38","author":"Giannaccare","year":"2019","journal-title":"Cornea"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/02713683.2014.884595","article-title":"Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye","volume":"39","author":"Li","year":"2014","journal-title":"Curr. Eye Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preteyeres.2017.05.003","article-title":"The role of systemic and topical fatty acids for dry eye treatment","volume":"61","author":"Barabino","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.2015.0047","article-title":"Recent advances in topical ocular drug delivery","volume":"32","author":"Yellepeddi","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2014.02.007","article-title":"Preparation and optimization of voriconazole microemulsion for ocular delivery","volume":"117","author":"Kumar","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mahran, A., Ismail, S., and Allam, A.A. (2021). Development of triamcinolone acetonide-loaded microemulsion as a prospective ophthalmic delivery system for treatment of uveitis: In vitro and in vivo evaluation. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040444"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4068\/cmj.2023.59.3.143","article-title":"Mechanistic insight into age-related macular degeneration (AMD): Anatomy, epidemiology, genetics, pathogenesis, prevention, implications, and treatment strategies to pace AMD management","volume":"59","author":"Amini","year":"2023","journal-title":"Chonnam Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Shi, J., Yang, J., Xu, H., Luo, Q., Sun, J., Zhang, Y., Liang, Z., Zhao, N., and Zhang, J. (2023). Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization in vitro and in vivo. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1157084"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1208\/s12249-017-0933-8","article-title":"\u03c9-3 Fatty acid synergized novel nanoemulsifying system for rosuvastatin delivery: In vitro and in vivo evaluation","volume":"19","author":"Tripathi","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kang, S.G., Lee, G.B., Vinayagam, R., Do, G.S., Oh, S.Y., Yang, S.J., Kwon, J.B., and Singh, M. (2022). Anti-inflammatory, antioxidative, and nitric oxide-scavenging activities of a quercetin nanosuspension with polyethylene glycol in LPS-induced RAW 264.7 macrophages. Molecules, 27.","DOI":"10.3390\/molecules27217432"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104077","DOI":"10.1016\/j.micpath.2020.104077","article-title":"Alpha-linolenic acid protects against lipopolysaccharide-induced acute lung injury through anti-inflammatory and anti-oxidative pathways","volume":"142","author":"Zhu","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1007\/s12010-024-05003-4","article-title":"Anti-inflammatory effects of quercetin, rutin, and troxerutin result from the inhibition of NO production and the reduction of COX-2 levels in RAW 264.7 cells treated with LPS","volume":"196","author":"Lee","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Stanca, H.T. (2024). Age-Related Macular Degeneration (AMD). Clinical Ophthalmology: A Guide to Diagnosis and Treatment, Springer.","DOI":"10.1007\/978-3-031-68453-1_17"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Parmar, U.P.S., Surico, P.L., Mori, T., Singh, R.B., Cutrupi, F., Premkishore, P., Afflitto, G.G., Di Zazzo, A., Coassin, M., and Romano, F. (2025). Antioxidants in age-related macular degeneration: Lights and shadows. Antioxidants, 14.","DOI":"10.3390\/antiox14020152"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"77590","DOI":"10.1039\/C6RA15166C","article-title":"Development of an \u03b1-linolenic acid containing soft nanocarrier for oral delivery: In vitro and in vivo evaluation","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhou, K., Ye, C., Shang, Y., and Wang, F. (2025). Preparation and characterization of microemulsions formulated with PEG fatty acid glycerides. Colloids Surf. B Biointerfaces, 254.","DOI":"10.1016\/j.colsurfb.2025.114826"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/acs.jpcb.4c08376","article-title":"Thermodynamic explanation of surfactant-free microemulsions","volume":"129","author":"Ma","year":"2025","journal-title":"J. Phys. Chem. B"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s13346-017-0453-9","article-title":"Augmented bioavailability of felodipine through an \u03b1-linolenic acid-based microemulsion","volume":"8","author":"Singh","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_43","first-page":"455","article-title":"Ocular physiology and artificial tears","volume":"70","year":"1999","journal-title":"J. Am. Optom. Assoc."},{"key":"ref_44","first-page":"465","article-title":"Microemulsions as potential ocular drug delivery systems: Phase diagrams and physical properties depending on ingredients","volume":"62","author":"Wojciechowska","year":"2005","journal-title":"Acta Pol. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijbiomac.2021.09.069","article-title":"Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid)(PLGA) nanoparticles for potential treatment of age-related macular degeneration","volume":"191","author":"Suri","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zafar, S., Akhter, S., Ahmad, I., Hafeez, Z., Rizvi, M.M.A., Jain, G.K., and Ahmad, F.J. (2020). Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies. Colloids Surf. B Biointerfaces, 186.","DOI":"10.1016\/j.colsurfb.2019.110603"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/adt.2019.920","article-title":"Axitinib-loaded poly (lactic-co-glycolic acid) nanoparticles for age-related macular degeneration: Formulation development and in vitro characterization","volume":"17","author":"Narvekar","year":"2019","journal-title":"Assay. Drug Dev. Technol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.febslet.2008.08.005","article-title":"Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro","volume":"582","author":"Stahl","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21691401.2017.1408123","article-title":"Nanomedicine approaches for sirolimus delivery: A review of pharmaceutical properties and preclinical studies","volume":"46","author":"Haeri","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"119776","DOI":"10.1016\/j.ijpharm.2020.119776","article-title":"Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety","volume":"589","author":"Chatzitaki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10753-014-9857-6","article-title":"Anti-inflammatory potential of alpha-linolenic acid mediated through selective COX inhibition: Computational and experimental data","volume":"37","author":"Anand","year":"2014","journal-title":"Inflammation"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2030\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:51:45Z","timestamp":1763113905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["medicina61112030"],"URL":"https:\/\/doi.org\/10.3390\/medicina61112030","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}